miércoles , 29 mayo 2024

La inyección contra K0 B1T causa una amplia gama de trastornos de la piel

Print Friendly, PDF & Email

El público está en alerta por miocarditis, coágulos sanguíneos y daños neurológicos con la vacunación contra el COVID-19, pero ahora también se habla de nuevas erupciones cutáneas. Un artículo de Seirafianpour et al resumió 180 artículos/informes impresionantes de los primeros siete meses de la campaña de vacunación solamente, describiendo en tablas exhaustivas la amplia gama de erupciones cutáneas y trastornos de las superficies mucosas (boca/nariz/ano) donde la proteína pico, o Spike de la inyección y/o los mediadores inflamatorios provocan manifestaciones dermatológicas. Nunca ha habido una inyección que tenga este grado de toxicidad dermatológica grave y bien documentada.

Al final del artículo hemos incluido 480 estudios más, revisados por pares sobre efectos adversos de la Inyección K0 B1T en la piel

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111423/pdf/DTH-35-0.pdf

Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423.Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. Una revisión sistemática sobre presentaciones mucocutáneas después de la vacunación contra el COVID-19 y recomendaciones de expertos sobre la vacunación de importantes trastornos dermatológicos inmunomediados. Dermatol Ther. 2022 junio;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 11 de abril. PMID: 35316551; PMCID: PMC9111423.

Uno de los principales hallazgos de los autores es: “Los efectos secundarios se informaron con mayor frecuencia dentro de los primeros 3 días después de la vacunación, pero también hubo algunos estudios que informaron reacciones adversas tardías, hasta 4 semanas después de la vacunación. 

La duración de las reacciones varió desde casi 1 día con mayor frecuencia hasta 4 semanas o más. La localización más frecuente de las lesiones mucocutáneas fue en miembros superiores (lugar de inyección), tronco y cara. 

Casi la mitad de estos estudios informaron las comorbilidades de los participantes. Las comorbilidades más comúnmente reportadas fueron:

  • hipertensión,
  • antecedentes de COVID-19,
  • diabetes mellitus,
  • trastornos cardiovasculares,
  • autoinmunes,
  • reumatológicos o
  • alérgicos,
  • neoplasias malignas,
  • obesidad y
  • anafilaxia”.

https://openvaers.com/covid-data/shingles

Este estudio deja en claro que si uno tiene un trastorno autoinmune o alérgico al inicio, entonces una inyección COVID-19 está causando un gran problema. Otras condiciones enumeradas deberían servir como advertencias similares. 

Muchas de estas erupciones son duraderas, requerirán citas dermatológicas y, en algunos casos, necesitarán infusiones intravenosas intermitentes y costosas. Se ha recomendado que las inyecciones se retiren del mercado y en este momento no se pueden recomendar a nadie.

Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423.

Covid-19 Vaccine Pharmacovigilance Report: Urgent Recall, Posted on June 11, 2022 Updated on January 20, 2023

Si encuentra “ este artículo útil suscríbase como miembro de nuestro equipo para apoyarnos y en conjunto podamos aclarar el tema en discusiones con familiares, amigos, funcionarios y empleadores. L Muchas gracias. Puede Apoyarnos en  https://cienciaysaludnatural.com/colaboracion

Colabore por favor con nosotros para que podamos llegar a más personas: contribución en mercado pago o paypal por única vez, Muchas Gracias!

10.000$ar https://mpago.la/1srgnEY
5.000$ar https://mpago.la/1qzSyt9
1.000$ar  https://mpago.la/1Q1NEKM
Via PAYPAL: Euros o dólares click aqui
Solicite nuestro CBU contactenos

480 Estudios más sobre efectos adversos de la Inyección K0 B1T en la piel

https://pubmed.ncbi.nlm.nih.gov/34742927/A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine – PubMedAbobaker et al
https://pubmed.ncbi.nlm.nih.gov/33783017/Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccineAckerman et al
https://pubmed.ncbi.nlm.nih.gov/34686374/Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccineAgharbi et al
https://pubmed.ncbi.nlm.nih.gov/35218057/Cutaneous reactions after coronavirus disease 2019 vaccination: Summary of 20 Japanese casesAkatsuka et al
https://pubmed.ncbi.nlm.nih.gov/35187768/Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravationAkoglu
https://pubmed.ncbi.nlm.nih.gov/34236714/Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?Aktas & Ertuğrul
https://pubmed.ncbi.nlm.nih.gov/35371700/Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 VaccineAlamri et al
https://pubmed.ncbi.nlm.nih.gov/34391695/Palms and soles itchiness as a side effect of COVID-19 vaccinationAl-Ansari et al
https://pubmed.ncbi.nlm.nih.gov/35386174/Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of LiteratureAlrawashdeh et al
https://pubmed.ncbi.nlm.nih.gov/35251600/Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report – PubMedAlshammari et al
https://pubmed.ncbi.nlm.nih.gov/35422564/Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 VaccineAlzoabi et al
https://pubmed.ncbi.nlm.nih.gov/34545609/Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccineAoki et al
https://pubmed.ncbi.nlm.nih.gov/35449768/Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infectionAryanian et al (1)
https://pubmed.ncbi.nlm.nih.gov/34791786/Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administrationAtak et al
https://pubmed.ncbi.nlm.nih.gov/35067994/Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et alAvallone et al
https://pubmed.ncbi.nlm.nih.gov/34997985/Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccineAwada et al
https://pubmed.ncbi.nlm.nih.gov/34835143/Sweet Syndrome Following SARS-CoV2 VaccinationBaffa et al (1)
https://pubmed.ncbi.nlm.nih.gov/35308065/A case report of anti-P200 pemphigoid following COVID-19 vaccinationBailly-Caillé et al
https://pubmed.ncbi.nlm.nih.gov/34748655/Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature reviewBalogun et al
https://pubmed.ncbi.nlm.nih.gov/35062748/Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy AdultBarry et al
https://pubmed.ncbi.nlm.nih.gov/34272069/[Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine]Bekkali et al
https://pubmed.ncbi.nlm.nih.gov/34423105/Lichen striatus post-COVID-19 vaccinationBelina et al
https://pubmed.ncbi.nlm.nih.gov/35288926/SARS-CoV-2 vaccine induced Sweet syndrome : a case reportBen Rejeb et al
https://pubmed.ncbi.nlm.nih.gov/34473839/Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccineBonino et al
https://pubmed.ncbi.nlm.nih.gov/34547125/Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiformeBorg et al
https://pubmed.ncbi.nlm.nih.gov/34606671/Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidenceBrooks SG et al
https://pubmed.ncbi.nlm.nih.gov/35224170/New-onset of vitiligo in a child following COVID-19 vaccinationBukhari
https://pubmed.ncbi.nlm.nih.gov/35148438/Reply to «COVID vaccine-induced lichen planus on areas previously affected by vitiligo»Bularca et al
https://pubmed.ncbi.nlm.nih.gov/34837354/Cutaneous reactions to COVID-19 vaccine at the dermatology primary careBurlando et al
https://pubmed.ncbi.nlm.nih.gov/34902185/Reply to ‘New-onset cutaneous lichen planus triggered by COVID-19 vaccination’ by Merhy et alCamela et al
https://pubmed.ncbi.nlm.nih.gov/34236735/Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccineCameli et al (1)
https://pubmed.ncbi.nlm.nih.gov/34214206/AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case reportCapassoni et al
https://pubmed.ncbi.nlm.nih.gov/35266259/Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccineCaroppo et al
https://pubmed.ncbi.nlm.nih.gov/34254291/Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 casesCatalà et al
https://pubmed.ncbi.nlm.nih.gov/35455281/Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation?Cazzato et al (1)
https://pubmed.ncbi.nlm.nih.gov/35434826/Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature reviewChahed et al
https://pubmed.ncbi.nlm.nih.gov/34751491/Sudden onset of vitiligo after COVID-19 vaccineCiccarese et al (1)
https://pubmed.ncbi.nlm.nih.gov/35247654/Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccinationCole et al
https://pubmed.ncbi.nlm.nih.gov/34557622/Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccineColia et al
https://pubmed.ncbi.nlm.nih.gov/33834563/Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case seriesCorbeddu et al
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8444733/Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature – PMCCoto‐Segura et al
https://pubmed.ncbi.nlm.nih.gov/33982814/Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 VaccineCyrenn et al
https://pubmed.ncbi.nlm.nih.gov/34169578/The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?Damiani et al
https://pubmed.ncbi.nlm.nih.gov/33620081/‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccineDavido et al
https://pubmed.ncbi.nlm.nih.gov/34854640/[A red and swollen arm after vaccination for covid-19]De Mik et al
https://pubmed.ncbi.nlm.nih.gov/34786801/Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapyDell’Antonia et al
https://pubmed.ncbi.nlm.nih.gov/34730195/Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccineDheir et al
https://pubmed.ncbi.nlm.nih.gov/34953018/Lichen planus and lichen planopilaris flare after COVID-19 vaccinationDiab et al
https://www.mdpi.com/2076-393X/10/4/602Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? (Breastfeeding Infant AE) Vaccines | Free Full-Text | Diogo et al
https://pubmed.ncbi.nlm.nih.gov/35199304/Persistent pruritus following COVID-19 vaccinationDoyle & Watchorn
https://pubmed.ncbi.nlm.nih.gov/35237629/Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 InfectionDrenovska et al
https://pubmed.ncbi.nlm.nih.gov/35133700/Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasisDurmus et al
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8447368/Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine – PMCFalkenhain‐López et al
https://pubmed.ncbi.nlm.nih.gov/35211310/De novo and relapsing necrotizing vasculitis after COVID-19 vaccinationFillon et al
https://pubmed.ncbi.nlm.nih.gov/33725406/Prompt onset of Rowell’s syndrome following the first BNT162b2 SARS-CoV-2 vaccinationGambichler et al (1)
https://pubmed.ncbi.nlm.nih.gov/35132838/Dermatomyositis Following BNT162b2 mRNA COVID-19 VaccinationGouda et al
https://pubmed.ncbi.nlm.nih.gov/34416053/‘COVID vaccine arm’ may present after both mRNA vaccines vaccinationGregoriou et al
https://pubmed.ncbi.nlm.nih.gov/34585371/A case of COVID-19 vaccination-associated forme fruste purpura fulminansGriss et al
https://pubmed.ncbi.nlm.nih.gov/33982318/Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccineGyldenløve et al
https://pubmed.ncbi.nlm.nih.gov/34762342/Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccineHali F et al
https://pubmed.ncbi.nlm.nih.gov/35425676/Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five CasesHali Sr ete al
https://pubmed.ncbi.nlm.nih.gov/35571457/Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafineHan J et al
https://pubmed.ncbi.nlm.nih.gov/34934493/Lichen planus flare following COVID-19 vaccination: A case reportHerzum et al
https://pubmed.ncbi.nlm.nih.gov/33724563/Lichen planus arising after COVID-19 vaccinationHiltun et al
https://pubmed.ncbi.nlm.nih.gov/34423106/A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology – PubMedHolmes et al
https://pubmed.ncbi.nlm.nih.gov/34379821/Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccineHunjan et al
https://pubmed.ncbi.nlm.nih.gov/35293793/Leukocytoclastic Vasculitic Rash Following Second Dose of Moderna COVID-19 VaccineIreifej et al
https://pubmed.ncbi.nlm.nih.gov/34513435/Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine – PubMedIrvine & Wiles
https://pubmed.ncbi.nlm.nih.gov/34546346/Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccinationIshizuka et al
https://pubmed.ncbi.nlm.nih.gov/33560802/Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccineJedlowski & Jedlowski
https://pubmed.ncbi.nlm.nih.gov/33978670/Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case SeriesJohnston et al
https://pubmed.ncbi.nlm.nih.gov/34455671/Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccineJoseph & Chong
https://pubmed.ncbi.nlm.nih.gov/34603727/New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination – PubMedKaminetzky & Rudikoff
https://pubmed.ncbi.nlm.nih.gov/35263820/Oral lichen planus following mRNA COVID-19 vaccinationKaomongkolgit & Sawangarun
https://pubmed.ncbi.nlm.nih.gov/34162525/«COVID Toes» After mRNA COVID-19 VaccinesKelso et al
https://pubmed.ncbi.nlm.nih.gov/34242422/‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccineKempf et al
https://pubmed.ncbi.nlm.nih.gov/34423142/Moderna COVID-19 vaccine induced skin rash – PMCKhalid et al
https://pubmed.ncbi.nlm.nih.gov/34751429/A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination – PMCKherlopian et al
https://pubmed.ncbi.nlm.nih.gov/34661942/Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)Kim MJ et al
https://pubmed.ncbi.nlm.nih.gov/35357514/[Delayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273-a previously undescribed reaction pattern of COVID arm]Kofler & Forchhammer
https://pubmed.ncbi.nlm.nih.gov/34294590/Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report – PubMedKong et al
https://pubmed.ncbi.nlm.nih.gov/34131967/Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccineKrajewski et al
https://pubmed.ncbi.nlm.nih.gov/34291477/Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccinationKreuter et al
https://pubmed.ncbi.nlm.nih.gov/34292611/Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccinationLarson et al
https://pubmed.ncbi.nlm.nih.gov/33914926/A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccineLavery et al
https://pubmed.ncbi.nlm.nih.gov/34557507/Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination – PubMedLeerunyakul et al
https://pubmed.ncbi.nlm.nih.gov/34131969/Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2Lesort et al
https://pubmed.ncbi.nlm.nih.gov/34120504/COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as CellulitisLindgren et al
https://pubmed.ncbi.nlm.nih.gov/35130405/New-onset cutaneous lupus erythematosus after the COVID-19 vaccineLiu & Messenger
https://pubmed.ncbi.nlm.nih.gov/33893637/Pernio after COVID-19 vaccinationLopez S et al
https://pubmed.ncbi.nlm.nih.gov/33855706/Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccineLópez-Valle et al
https://pubmed.ncbi.nlm.nih.gov/34590397/Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female – PubMedMajid & Mearaj
https://pubmed.ncbi.nlm.nih.gov/35356381/Woman with pruritic rash and dermatographismMalcolm & Shah
https://pubmed.ncbi.nlm.nih.gov/35295599/Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre StudyMaronese et al
https://pubmed.ncbi.nlm.nih.gov/34936145/Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)Masseran et al
https://pubmed.ncbi.nlm.nih.gov/34048614/Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?Mazzatenta et al
https://pubmed.ncbi.nlm.nih.gov/34210829/A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?Meara et al
https://pubmed.ncbi.nlm.nih.gov/34236718/New-onset cutaneous lichen planus triggered by COVID-19 vaccinationMerhy et al
https://pubmed.ncbi.nlm.nih.gov/34319363/Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 VaccineMerrill et al
https://pubmed.ncbi.nlm.nih.gov/35145806/Vitiligo Possibly Triggered by COVID-19 VaccinationMilitello et al
https://pubmed.ncbi.nlm.nih.gov/35536295/Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine – A series of 37 casesMohta & Sharma
https://pubmed.ncbi.nlm.nih.gov/34547138/Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccineMontjoye et al
https://pubmed.ncbi.nlm.nih.gov/33559733/«COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment»Munavalli et al (1)
https://pubmed.ncbi.nlm.nih.gov/34676639/Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccinationMyrdal et al
https://pubmed.ncbi.nlm.nih.gov/34545973/Case of bullous pemphigoid following coronavirus disease 2019 vaccinationNakamura et al
https://pubmed.ncbi.nlm.nih.gov/35137500/Figurate purpuric eruption post-COVID-19 vaccinationNamazi et al
https://pubmed.ncbi.nlm.nih.gov/34075664/Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccineNiebel et al (1)
https://pubmed.ncbi.nlm.nih.gov/34167874/Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestationsOhsawa et al
https://pubmed.ncbi.nlm.nih.gov/34931408/Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccineOkan & Vural
https://pubmed.ncbi.nlm.nih.gov/35455266/Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 mRNA VaccinationOkazaki et al
https://pubmed.ncbi.nlm.nih.gov/35169602/Severe flare of pemphigus vulgaris after first dose of COVID-19 vaccineOng et al
https://pubmed.ncbi.nlm.nih.gov/34631106/Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administrationOnn & Chang
https://pubmed.ncbi.nlm.nih.gov/35097176/Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccinePaolino & Rongioletti
https://pubmed.ncbi.nlm.nih.gov/35224780/Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumabPavia et al
https://pubmed.ncbi.nlm.nih.gov/34533265/Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature reviewPedrazini & da Silva
https://pubmed.ncbi.nlm.nih.gov/34119340/Bullous pemphigoid and COVID-19 vaccinePérez-López et al (1)
https://pubmed.ncbi.nlm.nih.gov/35331228/Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four casesPertruzzi et al
https://pubmed.ncbi.nlm.nih.gov/33914966/BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2Piccolo et al (1)
https://pubmed.ncbi.nlm.nih.gov/34547122/COVID vaccine-induced lichen planus on areas previously affected by vitiligoPiccolo et al (2)
https://pubmed.ncbi.nlm.nih.gov/34750923/«Covid arm»: Abnormal side effect after Moderna COVID-19 vaccinePicone et al (1)
https://pubmed.ncbi.nlm.nih.gov/35167108/A Case of New-Onset Lichen Planus after COVID-19 VaccinationPicone et al (2)
https://pubmed.ncbi.nlm.nih.gov/33904168/Chilblain lesions after COVID-19 mRNA vaccinePileri et al
https://pubmed.ncbi.nlm.nih.gov/34983709/Delayed systemic urticarial reactions following mRNA COVID-19 vaccinationPitlick et al
https://pubmed.ncbi.nlm.nih.gov/34570195/Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as MechanismQiao et al
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112292/Acral hemorrhages after administration of the second dose of the SARS-CoV-2 vaccine. A post-vaccination reaction? – PMCRamos et al
https://pubmed.ncbi.nlm.nih.gov/35291527/Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence?Rashid MRA et al
https://pubmed.ncbi.nlm.nih.gov/34928536/SCLE manifestation after mRNA COVID-19 vaccinationRechtien et al
https://pubmed.ncbi.nlm.nih.gov/34310777/New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three casesRevilla-Nebreda et al
https://pubmed.ncbi.nlm.nih.gov/35393710/COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccineRiquelme et al
https://pubmed.ncbi.nlm.nih.gov/34617317/Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccineSechi et al
https://pubmed.ncbi.nlm.nih.gov/35305031/Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthemaSechi et al
https://pubmed.ncbi.nlm.nih.gov/35349766/Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from BrazilSeque et al
https://pubmed.ncbi.nlm.nih.gov/34751995/Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruptionSernicola et al
https://pubmed.ncbi.nlm.nih.gov/34606669/Development of oral lichen planus after COVID-19 vaccination – a rare case reportSharda et al
https://pubmed.ncbi.nlm.nih.gov/34109263/Localized and generalized urticarial allergic dermatitis secondary to SARS-CoV-2 vaccination in a series of 6 patientsSidlow et al
https://pubmed.ncbi.nlm.nih.gov/34169588/Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2Solimani et al
https://pubmed.ncbi.nlm.nih.gov/34396420/Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case ReportSouaid et al
https://pubmed.ncbi.nlm.nih.gov/35224171/Sclerotic skin disease development following COVID-19 vaccinationSprow et al
https://pubmed.ncbi.nlm.nih.gov/34351606/Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2Sprute et al
https://pubmed.ncbi.nlm.nih.gov/35191544/Exacerbation of systemic lupus erythematosus after receiving mRNA-1273-based coronavirus disease 2019 vaccineSugimoto et al
https://pubmed.ncbi.nlm.nih.gov/34897823/Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiaeTatu et al
https://pubmed.ncbi.nlm.nih.gov/33900629/Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccinationTemmiz et al
https://pubmed.ncbi.nlm.nih.gov/34459036/Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccinesTihy et al
https://pubmed.ncbi.nlm.nih.gov/34275656/Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccinationTomayko et al
https://pubmed.ncbi.nlm.nih.gov/34543493/Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)Troeltzsch et al
https://pubmed.ncbi.nlm.nih.gov/35152540/Newly-developed vitiligo following COVID-19 mRNA vaccineUğurer et al
https://pubmed.ncbi.nlm.nih.gov/34726187/Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?Ungari & Pezzarossa
https://pubmed.ncbi.nlm.nih.gov/34547113/Early atypical injection‐site reactions to COVID‐19 vaccine: a case seriesVaccaro et al
https://pubmed.ncbi.nlm.nih.gov/35167784/Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel VaccineValk & Bender
https://pubmed.ncbi.nlm.nih.gov/34588156/Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 VaccineVecillas et al
https://pubmed.ncbi.nlm.nih.gov/34100306/Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patientWeinstock-Guttman & Jakimovski
https://pubmed.ncbi.nlm.nih.gov/34676438/[Erythema multiforme following COVID-19 vaccination (BNT162b2)]Wunderlich & Dirschka
https://pubmed.ncbi.nlm.nih.gov/34862669/Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccinationYatsuzuka et al
https://pubmed.ncbi.nlm.nih.gov/35170156/New onset of pemphigus foliaceus following BNT162b2 vaccineYıldırıcı et al
https://pubmed.ncbi.nlm.nih.gov/34547137/A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccineYoung J et al
https://pubmed.ncbi.nlm.nih.gov/34817862/Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccineŽagar et al
https://pubmed.ncbi.nlm.nih.gov/35147269/New-onset lichen planus arising after COVID-19 vaccinationZagaria et al
https://pubmed.ncbi.nlm.nih.gov/35174595/Lichen Ruber Planus occurring after SARS-CoV-2 vaccinationZengarini et al (1)
https://pubmed.ncbi.nlm.nih.gov/34807495/Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitisZengarini et al (2)
https://pubmed.ncbi.nlm.nih.gov/34726769/Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccinationGamblichler et al (2)
https://pubmed.ncbi.nlm.nih.gov/33991162/20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social mediaLee C et al
https://pubmed.ncbi.nlm.nih.gov/34327795/Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccineVassallo et al
https://pubmed.ncbi.nlm.nih.gov/35306713/SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature reviewAbdelmaksoud et al
https://pubmed.ncbi.nlm.nih.gov/35141951/Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccinationGambichler et al (3)
https://pubmed.ncbi.nlm.nih.gov/34853744/Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 VaccineShahrigharahkoshan et al
https://pubmed.ncbi.nlm.nih.gov/34599716/Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccinationLiang et al
https://pubmed.ncbi.nlm.nih.gov/34236717/Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccineFalkenhain-López et al
https://pubmed.ncbi.nlm.nih.gov/34247902/Henoch-Schönlein purpura presenting post COVID-19 vaccinationHines et al
https://pubmed.ncbi.nlm.nih.gov/35361289/Dermatomyositis post vaccine against SARS-COV2Coronel et al
https://pubmed.ncbi.nlm.nih.gov/34482558/Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccinationWantavornprasert et al
https://pubmed.ncbi.nlm.nih.gov/34399001/Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccinationLim & Wylie
https://pubmed.ncbi.nlm.nih.gov/34398977/De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccineElamin et al
https://pubmed.ncbi.nlm.nih.gov/35306720/Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2Tran TB et al
https://pubmed.ncbi.nlm.nih.gov/35299937/A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasisNorimatsu & Norimatsu
https://pubmed.ncbi.nlm.nih.gov/35285114/A case of new-onset acute generalized pustular psoriasis following Pfizer-BioNTech COVID-19 vaccineFrioui et al
https://pubmed.ncbi.nlm.nih.gov/35315189/Pustular rash triggered by Pfizer-BioNTech COVID-19 vaccination: A case reportRouai et al
https://pubmed.ncbi.nlm.nih.gov/34522741/Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccinePerna et al
https://pubmed.ncbi.nlm.nih.gov/35066960/Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID-19 vaccine: A report of three casesDurmaz et al
https://pubmed.ncbi.nlm.nih.gov/35344627/Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccinelahouel et al
https://pubmed.ncbi.nlm.nih.gov/35106762/Cutaneous polyarteritis nodosa following ChAdOx1 nCoV-19 vaccinationSu HA et al (1)
https://pubmed.ncbi.nlm.nih.gov/34696186/Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case ReportSirufo et al
https://pubmed.ncbi.nlm.nih.gov/34129749/Localized cutaneous reaction to an mRNA COVID-19 vaccineEdriss et al
https://pubmed.ncbi.nlm.nih.gov/34250736/Erythema migrans-like rash after Moderna vaccine: An uncommon type of «COVID arm»Zengarini et al (3)
https://pubmed.ncbi.nlm.nih.gov/34813953/Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rashStoyanov et al
https://pubmed.ncbi.nlm.nih.gov/33657292/Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2Blumenthal et al
https://pubmed.ncbi.nlm.nih.gov/33882228/Delayed Large Local Reactions to mRNA VaccinesBaeck et al
https://pubmed.ncbi.nlm.nih.gov/34459023/Five Japanese cases of delayed large local reactions to coronavirus disease 2019 vaccinesSato
https://pubmed.ncbi.nlm.nih.gov/34603964/Delayed large pruritic eruption to the BNT162b2 mRNA vaccineTerashima
https://pubmed.ncbi.nlm.nih.gov/34310755/A skin reaction with rust-like discolouration to mRNA COVID-19 vaccinePasternack & Pohjavaara
https://pubmed.ncbi.nlm.nih.gov/34657348/Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine’Kouki et al
https://pubmed.ncbi.nlm.nih.gov/34166540/Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?Kim JE et al
https://pubmed.ncbi.nlm.nih.gov/34698094/Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 VaccinesNiebel et al (2)
https://pubmed.ncbi.nlm.nih.gov/35308066/Erythema nodosum after COVID-19 vaccination in a pediatric patientHafer et al
https://pubmed.ncbi.nlm.nih.gov/34662466/Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccineCameli et al (2)
https://pubmed.ncbi.nlm.nih.gov/34934549/First Case of Erythema Nodosum Associated With Pfizer VaccineAly et al
https://pubmed.ncbi.nlm.nih.gov/34977819/Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineWu X et al
https://pubmed.ncbi.nlm.nih.gov/34416052/Flagellate purpura associated with COVID-19 vaccinationHeck et al
https://pubmed.ncbi.nlm.nih.gov/35296923/[Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?]Bramhoff et al
https://pubmed.ncbi.nlm.nih.gov/35284230/Fasciitis of the lower leg after COVID-19 vaccinationIde et al
https://pubmed.ncbi.nlm.nih.gov/35194793/Unusual contact dermatitis after SARS-CoV-2 vaccinationsJungwirth et al
https://pubmed.ncbi.nlm.nih.gov/34913043/Shoulder injury related to COVID-19 vaccine administration: a case reportWharton et al
https://pubmed.ncbi.nlm.nih.gov/34402098/Two cases of mild systemic adverse skin eruption after coronavirus disease 2019 vaccinationNanamori et al
https://pubmed.ncbi.nlm.nih.gov/34363258/Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)Juay & Chandran
https://pubmed.ncbi.nlm.nih.gov/34337117/Skin necrosis at both COVID-19 vaccine injection sitesGruenstein & Levitt
https://pubmed.ncbi.nlm.nih.gov/34839563/Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccinationKuzumi et al
https://pubmed.ncbi.nlm.nih.gov/34358176/Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and PerspectivesCazzato et al (2)
https://pubmed.ncbi.nlm.nih.gov/34293500/Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19Guerrero et al
https://pubmed.ncbi.nlm.nih.gov/33864927/«COVID Arm»: Very delayed large injection site reactions to mRNA COVID-19 vaccinesRamos & Kelso
https://pubmed.ncbi.nlm.nih.gov/34102322/Delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccineGrobusch et al
https://pubmed.ncbi.nlm.nih.gov/34276178/Delayed Skin Rash After Receiving SARS-CoV-2 mRNA Moderna VaccinePapamanoli et al
https://pubmed.ncbi.nlm.nih.gov/34236729/Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccineLeasure et al
https://pubmed.ncbi.nlm.nih.gov/34236711/Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literatureCoto-Segura et al
https://pubmed.ncbi.nlm.nih.gov/34129694/Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccineShin E et al
https://pubmed.ncbi.nlm.nih.gov/34086881/Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital EmployeesJacobson et al
https://pubmed.ncbi.nlm.nih.gov/34031953/Local reactions to the second dose of the BNT162 COVID-19 vaccineTammaro et al
https://pubmed.ncbi.nlm.nih.gov/33996313/BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare WorkersLopatynsky-Reyes et al
https://pubmed.ncbi.nlm.nih.gov/34930152/Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reportsMohamed L et al
https://pubmed.ncbi.nlm.nih.gov/35305036/Transient inflammation in surgical scars following Covid-19 mRNA vaccinationFerreli et al
https://pubmed.ncbi.nlm.nih.gov/34344774/Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccineLim D WT et al
https://pubmed.ncbi.nlm.nih.gov/35398905/Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysisPadniewski et al
https://pubmed.ncbi.nlm.nih.gov/35274363/Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)Salem et al
https://pubmed.ncbi.nlm.nih.gov/34582621/Oral pemphigus after COVID-19 vaccinationThongprasom et al
https://pubmed.ncbi.nlm.nih.gov/34718079/Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine – A Case ReportDrucker et al
https://pubmed.ncbi.nlm.nih.gov/34706274/Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 VaccinationWojcicki & O’Brien
https://pubmed.ncbi.nlm.nih.gov/34888935/Vulvar aphthous ulcer after COVID-19 vaccinationPopatia & Chiu
https://pubmed.ncbi.nlm.nih.gov/35413297/Acute Genital Ulceration After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and InfectionHsu T et al
https://pubmed.ncbi.nlm.nih.gov/35114426/Ulcers on the bilateral palate mucosa following mRNA-based vaccination for coronavirus disease 2019 (COVID-19): A case reportMaeda et al
https://pubmed.ncbi.nlm.nih.gov/35260129/Various painful oral adverse reactions following COVID-19 vaccination: a case seriesChun Y et al
https://pubmed.ncbi.nlm.nih.gov/34753210/Eosinophilic dermatosis after AstraZeneca COVID-19 vaccinationCinotti et al
https://pubmed.ncbi.nlm.nih.gov/34487570/Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccineFang et al
https://pubmed.ncbi.nlm.nih.gov/34231301/Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitorMieczkowska et al
https://pubmed.ncbi.nlm.nih.gov/34363647/Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centreSotiriou et al
https://pubmed.ncbi.nlm.nih.gov/35015916/COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasisPiccolo et al
https://pubmed.ncbi.nlm.nih.gov/34309932/New onset of mainly guttate psoriasis after COVID-19 vaccination: a case reportLehmann et al
https://pubmed.ncbi.nlm.nih.gov/34236728/New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccinationQuattrini et al
https://pubmed.ncbi.nlm.nih.gov/34348912/Remitting seronegative symmetrical synovitis with pitting oedema following BNT162b2 mRNA COVID-19 vaccinationParperis & Constantinou
https://pubmed.ncbi.nlm.nih.gov/35236680/Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisyShimagami et al
https://pubmed.ncbi.nlm.nih.gov/35079580/Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccinesThe & Leow
https://pubmed.ncbi.nlm.nih.gov/34350668/Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two casesNagrani et al
https://pubmed.ncbi.nlm.nih.gov/34713443/De novo guttate psoriasis following coronavirus disease 2019 vaccinationSong WJ et al
https://pubmed.ncbi.nlm.nih.gov/35176180/A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccineOhmura et al
https://pubmed.ncbi.nlm.nih.gov/35004790/Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single CenterHuang & Tsai
https://pubmed.ncbi.nlm.nih.gov/35170153/Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccinationNia et al
https://pubmed.ncbi.nlm.nih.gov/34363731/Pityriasis rosea following SARS-CoV-2 vaccination: A case seriesTemiz et al
https://pubmed.ncbi.nlm.nih.gov/34237178/Pityriasis rosea developing after COVID-19 vaccinationMarcantonio-Santa Cruz et al
https://pubmed.ncbi.nlm.nih.gov/34110010/Pityriasis rosea after mRNA COVID-19 vaccinationAbdullah et al
https://pubmed.ncbi.nlm.nih.gov/34740803/Pityriasis Rosea Shortly After mRNA-1273 COVID-19 VaccinationShin SH et al
https://pubmed.ncbi.nlm.nih.gov/34165237/Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young maleAdya et al
https://pubmed.ncbi.nlm.nih.gov/33904157/Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccinationCarballido Vázquez & Morgado
https://pubmed.ncbi.nlm.nih.gov/34435935/Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccineCohen et al
https://pubmed.ncbi.nlm.nih.gov/35156062/Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literatureBuckley et al
https://pubmed.ncbi.nlm.nih.gov/35012825/Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature reviewWang CS et al
https://pubmed.ncbi.nlm.nih.gov/34585750/Atypical pityriasis rosea associated with mRNA COVID-19 vaccineBostan & Jarbou
https://pubmed.ncbi.nlm.nih.gov/35518792/Inverse pityriasis rosea secondary to COVID-19 vaccinationFenner et al
https://pubmed.ncbi.nlm.nih.gov/34762355/Benign cutaneous reactions post-COVID-19 vaccination: A case series of 16 patients from a tertiary care center in IndiaAgarwal et al
https://pubmed.ncbi.nlm.nih.gov/34436620/Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 VaccinationArmoni-Weiss et al
https://pubmed.ncbi.nlm.nih.gov/35211316/De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccinationOniszczuk et al
https://pubmed.ncbi.nlm.nih.gov/33998677/Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2Nanova et al
https://pubmed.ncbi.nlm.nih.gov/35429051/Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer)Zengarini et al (4)
https://pubmed.ncbi.nlm.nih.gov/34121663/Hypersensitivity to Covid-19 Vaccine Confirmed by a Positive Skin Test Result: A Case ReportPérez-Codesido et al
https://pubmed.ncbi.nlm.nih.gov/34132638/Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal TestingPickert et al
https://pubmed.ncbi.nlm.nih.gov/35664444/Vaccine Toes Are the New COVID ToesHodge et al
https://pubmed.ncbi.nlm.nih.gov/35256820/Acute exacerbation of psoriasis after COVID-19 Pfizer vaccinationLopez ED et al
https://pubmed.ncbi.nlm.nih.gov/35373779/Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine: a case reportPierobon et al
https://pubmed.ncbi.nlm.nih.gov/35252516/COVID-19 vaccine-associated dermatomyositisWu M et al
https://pubmed.ncbi.nlm.nih.gov/35049235/Transient lower extremity lymphedema following COVID-19 vaccination: A case reportChung JH et al
https://pubmed.ncbi.nlm.nih.gov/34920834/The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skinMagro et al
https://pubmed.ncbi.nlm.nih.gov/35355380/Dermatomyositis following COVID-19 vaccinationVenkateswaran et al
https://pubmed.ncbi.nlm.nih.gov/35223429/Post-COVID-19 vaccination shoulder abscess and pleuroparenchymal pulmonary lesion due to Burkholderia pseudomalleiMohanty et al
https://pubmed.ncbi.nlm.nih.gov/34310763/Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2Guzmán-Pérez et al
https://pubmed.ncbi.nlm.nih.gov/34363713/Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the PhilippinesYu JN et al
https://pubmed.ncbi.nlm.nih.gov/34703816/Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80Burlando et al
https://pubmed.ncbi.nlm.nih.gov/35470099/Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case reportLellig et al
https://pubmed.ncbi.nlm.nih.gov/34384729/Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case reportElboraey & Essa
https://pubmed.ncbi.nlm.nih.gov/35133674/Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccineAimo et al
https://pubmed.ncbi.nlm.nih.gov/34540442/Toxic Epidermal Necrolysis Post COVID-19 Vaccination – First Reported CaseBakir et al
https://pubmed.ncbi.nlm.nih.gov/34416058/A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccinationD’Cruz et al
https://pubmed.ncbi.nlm.nih.gov/34524252/Transient Eyelid Edema Following COVID-19 VaccinationAustria et al
https://pubmed.ncbi.nlm.nih.gov/34692313/Chronic Spontaneous Urticaria After COVID-19 VaccineThomas J et al
https://pubmed.ncbi.nlm.nih.gov/35284208/Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccinationSuan & Lee
https://pubmed.ncbi.nlm.nih.gov/34857596/COVID-19 vaccine-induced cellulitis and myositisRamalingam et al
https://pubmed.ncbi.nlm.nih.gov/34934701/Delayed-type hypersensitivity skin reaction to Covid-19 vaccineRobb & Robb
https://pubmed.ncbi.nlm.nih.gov/34611073/COVID Arm After Moderna Booster in Healthcare Worker: A Case ReportSaifuddin et al
https://pubmed.ncbi.nlm.nih.gov/34153381/Radiation Recall Phenomenon Following COVID-19 VaccinationStewart & McDowell
https://pubmed.ncbi.nlm.nih.gov/35103229/Breast Radiation Recall Phenomenon After Astra-Zeneca COVID-19 Vaccine: A Case SeriesMarples et al
https://pubmed.ncbi.nlm.nih.gov/33677050/COVID-19 Vaccine-Induced Radiation Recall PhenomenonSoyfer et al
https://pubmed.ncbi.nlm.nih.gov/35101198/In Regard to Soyfer et alEbner et al
https://pubmed.ncbi.nlm.nih.gov/35036285/Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccineIshikawa et al
https://pubmed.ncbi.nlm.nih.gov/34739397/Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 VaccinationHughes NM et al
https://pubmed.ncbi.nlm.nih.gov/34416044/Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinationsCiccarese et al (2)
https://pubmed.ncbi.nlm.nih.gov/34951399/Multiform Erythema After COVID-19 mRNA VaccinationMajenka et al
https://pubmed.ncbi.nlm.nih.gov/35615160/Case series ( Journal of The American Academy of Dermatology Cases Reports) Chronic spontaneous urticaria following COVID-19 vaccinationde Montjoye et al
https://pubmed.ncbi.nlm.nih.gov/34427024/Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two casesBostan E et ak
https://pubmed.ncbi.nlm.nih.gov/34937807/Delayed-type hypersensitivity reactions to Pfizer BioNTech SARS-CoV-2 vaccineBeyaz et al
https://pubmed.ncbi.nlm.nih.gov/35097177/Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case seriesKaratas et al
https://pubmed.ncbi.nlm.nih.gov/34693548/Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?Niebel et al (3)
https://pubmed.ncbi.nlm.nih.gov/34611542/Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineRicardo & Lipner
https://pubmed.ncbi.nlm.nih.gov/34978352/Sarcoidal immune reaction following SARS-CoV-2 vaccinationRached et al
https://pubmed.ncbi.nlm.nih.gov/35499440/An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccinationManci et al
https://pubmed.ncbi.nlm.nih.gov/34895746/Cutaneous vasculitis due to COVID-19 vaccinationGázquez Aguilera et al
https://pubmed.ncbi.nlm.nih.gov/34759023/Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA VaccineSy etal
https://pubmed.ncbi.nlm.nih.gov/35073431/Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccinationHung & Chi
https://pubmed.ncbi.nlm.nih.gov/34880971/Drug-induced lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria)Ziraldo et al
https://pubmed.ncbi.nlm.nih.gov/35522122/Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccinationIkediobi et al
https://pubmed.ncbi.nlm.nih.gov/35022253/Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein PupuraWang SSY
https://pubmed.ncbi.nlm.nih.gov/35431308/Erythema Multiforme after BNT162b2 VaccinationKatayama & Ota
https://pubmed.ncbi.nlm.nih.gov/35079635/Perniosis-like lesions after vaccination with mRNA against COVID-19Pérez-López et al (2)
https://pubmed.ncbi.nlm.nih.gov/35131890/Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccinationLee AYS et al
https://pubmed.ncbi.nlm.nih.gov/35075691/Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centreKoumaki et al (1)
https://pubmed.ncbi.nlm.nih.gov/35661906/Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based reviewGonzalez D et al
https://pubmed.ncbi.nlm.nih.gov/34776189/Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case reportKalia
https://pubmed.ncbi.nlm.nih.gov/35584258/Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccinesKoumaki et al (2)
https://pubmed.ncbi.nlm.nih.gov/33974494/Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccinationBrumfiel et al
https://pubmed.ncbi.nlm.nih.gov/34228815/Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccinationGambicher et al (4)
https://pubmed.ncbi.nlm.nih.gov/34478204/Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian countryChoi E et al
https://pubmed.ncbi.nlm.nih.gov/35607272/Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccineLuo & Oakley
https://pubmed.ncbi.nlm.nih.gov/35583958/New onset of psoriasis following COVID-19 vaccinationTran TNA et al
https://pubmed.ncbi.nlm.nih.gov/35073411/A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteinsMetin & Celepeli
https://pubmed.ncbi.nlm.nih.gov/35751559/Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature reviewBetetto et al
https://pubmed.ncbi.nlm.nih.gov/35698236/Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literaturePaparella et al
https://pubmed.ncbi.nlm.nih.gov/35613221/Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster dosesEyer-Silva & Leme
https://pubmed.ncbi.nlm.nih.gov/35606031/Erythema multiforme in a young adult following COVID-19 infection and vaccination in TanzaniaManji et al
https://pubmed.ncbi.nlm.nih.gov/35373396/Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cellWatanabe H et al
https://pubmed.ncbi.nlm.nih.gov/35348281/Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literatureSingh et al
https://pubmed.ncbi.nlm.nih.gov/35278243/Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence?Sun L et al
https://pubmed.ncbi.nlm.nih.gov/35258436/Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccineCook IF
https://pubmed.ncbi.nlm.nih.gov/34811862/COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigusHatami et al
https://pubmed.ncbi.nlm.nih.gov/35080255/Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one centerAfacan et al
https://pubmed.ncbi.nlm.nih.gov/34928518/Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature reviewPauluzzi et al
https://pubmed.ncbi.nlm.nih.gov/34773638/Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studiesGamblichler et al (5)
https://pubmed.ncbi.nlm.nih.gov/35031201/Morbilliform rashes as an unusual manifestation of vaccine-induced immune thrombotic thrombocytopeniaYang WT et al
https://pubmed.ncbi.nlm.nih.gov/34081806/COVID-19 vaccine-induced Stevens-Johnson syndromeDash S et al
https://pubmed.ncbi.nlm.nih.gov/34877762/Papular acrodermatitis of childhood-like eruption triggered by SARS-CoV-2 vaccination: Report of two casesVillagrasa-Boli et al
https://pubmed.ncbi.nlm.nih.gov/34874824/Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccineMoreno-Torres et al
https://pubmed.ncbi.nlm.nih.gov/35365342/Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccineJuddoo et al
https://pubmed.ncbi.nlm.nih.gov/35099065/Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccineCarrillo-Garcia et al
https://pubmed.ncbi.nlm.nih.gov/34984777/Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccineTeymour et al
https://pubmed.ncbi.nlm.nih.gov/35506318/Erythema nodosum after COVID-19 vaccineMaranini et al
https://pubmed.ncbi.nlm.nih.gov/34817063/An unusual presentation of pemphigus foliaceus following COVID-19 vaccinationLua ACY et al
https://pubmed.ncbi.nlm.nih.gov/34731529/Erythema annulare centrifugum induced by COVID-19 vaccinationKim JC et al
https://pubmed.ncbi.nlm.nih.gov/34720009/Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine boosterDicks & Gray
https://pubmed.ncbi.nlm.nih.gov/34699970/Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccineWatts MM et al
https://pubmed.ncbi.nlm.nih.gov/34663612/{Erythema at the site of a Bacille Calmette–Guérin vaccine scar after obtaining a dose of the SARS-CoV-2 messenger RNA vaccine} Érythème au site d’une cicatrice du vaccin bacille de Calmette–Guérin après l’obtention d’une dose du vaccin à ARN messager contre le SRAS-CoV-2Lim DWT et al
https://pubmed.ncbi.nlm.nih.gov/35567509/Marie Antoinette syndrome following COVID-19 vaccinationBaffa et al (2)
https://pubmed.ncbi.nlm.nih.gov/34291744/Unique Case of Urticarial Skin Eruptions After COVID-19 VaccinationBaraldi et al
https://pubmed.ncbi.nlm.nih.gov/34260095/Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?Hussain et al
https://pubmed.ncbi.nlm.nih.gov/34518832/Lymphadenopathy with florid lymphoid and Langerhans cell hyperplasia and hemophagocytosis mimicking lymphoma after COVID-19 mRNA vaccinationTintle & Chen
https://pubmed.ncbi.nlm.nih.gov/33972089/COVID arm and PET/FDG imagingBarriere & Bondouy
https://pubmed.ncbi.nlm.nih.gov/33835617/Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events: a case series of two patientsLam M et al
https://pubmed.ncbi.nlm.nih.gov/34594203/Darier’s Disease Flare following COVID-19 VaccineElbæk et al
https://pubmed.ncbi.nlm.nih.gov/33823270/Covid-19 vaccine and autoimmunity: Awakening the sleeping dragonAkinosoglou et al
https://pubmed.ncbi.nlm.nih.gov/34145775/Skin rashes after SARS-CoV-2 vaccine: which relationship, if any?Patruno et al
https://pubmed.ncbi.nlm.nih.gov/35066922/Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccinationOgawa et al
https://pubmed.ncbi.nlm.nih.gov/35049059/Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccineMontero-Menárguez et al
https://pubmed.ncbi.nlm.nih.gov/34841025/Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccineSowell et al
https://pubmed.ncbi.nlm.nih.gov/33997209/Widespread annular eruption after Ad26.COV2.S COVID-19 vaccineSong & Wong
https://pubmed.ncbi.nlm.nih.gov/35770484/New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2Gamonal et al
https://pubmed.ncbi.nlm.nih.gov/35789521/Intractable alopecia areata following the second dose of COVID-19 vaccination: Report of two casesChen CH et al
https://pubmed.ncbi.nlm.nih.gov/34559937/’Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor?Essam et al
https://pubmed.ncbi.nlm.nih.gov/35223675/Alopecia areata after COVID-19 vaccinationGallo et al
https://pubmed.ncbi.nlm.nih.gov/35107173/Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity?Lee MM et al
https://pubmed.ncbi.nlm.nih.gov/35571458/Letter in Reply: Alopecia areata after SARS-CoV-2 vaccinationLo et al
https://pubmed.ncbi.nlm.nih.gov/34741583/Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy – PubMedRossi et al
https://pubmed.ncbi.nlm.nih.gov/34931171/Alopecia areata after SARS-CoV-2 vaccinationScollan et al
https://pubmed.ncbi.nlm.nih.gov/35716105/Cutaneous manifestations following COVID-19 vaccination: A report of 25 casesShakoei et al
https://pubmed.ncbi.nlm.nih.gov/35642187/Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222)Ho JD et al
https://pubmed.ncbi.nlm.nih.gov/35379574/Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca)Su HA et al (2)
https://pubmed.ncbi.nlm.nih.gov/35070594/Alopecia Areata Treated with Advanced Platelet-rich Fibrin Using MicronizationVazquez et al
https://pubmed.ncbi.nlm.nih.gov/35771095/Influence of Covid-19 vaccination on immune-mediated skin diseasesAlelq et al
https://pubmed.ncbi.nlm.nih.gov/35754159/Cutaneous lupus erythematosus-like reaction arising after COVID-19 vaccinationRose C et al
https://pubmed.ncbi.nlm.nih.gov/35624558/Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccinationWang WY et al
https://pubmed.ncbi.nlm.nih.gov/35529074/A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccineWada et al
https://pubmed.ncbi.nlm.nih.gov/35465138/Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccineAjebo et al
https://pubmed.ncbi.nlm.nih.gov/35278239/Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoinCriado et al
https://pubmed.ncbi.nlm.nih.gov/35968197/Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 VaccinationCasale et al
https://pubmed.ncbi.nlm.nih.gov/36000937/Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testingSiripipattanamongkol et al
https://pubmed.ncbi.nlm.nih.gov/35986626/Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccineda Cruz Gouveia et al
https://pubmed.ncbi.nlm.nih.gov/35966160/Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccineMarcelino et al
https://pubmed.ncbi.nlm.nih.gov/34466640/Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccineAgaronov et al
https://pubmed.ncbi.nlm.nih.gov/34485656/Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccineDrohan et al
https://pubmed.ncbi.nlm.nih.gov/34485657/Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccineWong CY & Rios
https://pubmed.ncbi.nlm.nih.gov/34495381/Vasculitis and bursitis on [ 18 F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?Schierz et al
https://pubmed.ncbi.nlm.nih.gov/34611627/Cutaneous vasculitis following COVID-19 vaccinationCavalli et al
https://pubmed.ncbi.nlm.nih.gov/34746453/«COVID arm» detected by MR neurographyKomiya et al
https://pubmed.ncbi.nlm.nih.gov/34816549/Pityriasis rosea after Moderna mRNA-1273 vaccine: A case seriesMartora et al
https://pubmed.ncbi.nlm.nih.gov/34821411/A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccinationIwasawa et al (1)
https://pubmed.ncbi.nlm.nih.gov/34961975/Lichenoid drug eruption after coronavirus disease 2019 vaccinationBaba et al
https://pubmed.ncbi.nlm.nih.gov/35092306/Bullous neutrophilic dermatosis with severe acral oedema post-COVID-19 mRNA vaccinationGoubar et al
https://pubmed.ncbi.nlm.nih.gov/35184341/Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccinationMäkilä et al
https://pubmed.ncbi.nlm.nih.gov/35653233/Sweet-like syndrome and multiple COVID arm syndrome following COVID-19 vaccines: ‘specific’ patterns in a series of 192 patientsDarrigade et al
https://pubmed.ncbi.nlm.nih.gov/35698860/Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2Ramot et al
https://pubmed.ncbi.nlm.nih.gov/34337124/Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccinationBerry CT et al
https://pubmed.ncbi.nlm.nih.gov/34337193/Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 VaccineSalem F et al
https://pubmed.ncbi.nlm.nih.gov/34363637/Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureAnnabi et al
https://pubmed.ncbi.nlm.nih.gov/34366434/[Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine]González-Romero et al
https://pubmed.ncbi.nlm.nih.gov/34374333/Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19Dormann et al
https://pubmed.ncbi.nlm.nih.gov/34414254/Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathologyChopra et al
https://pubmed.ncbi.nlm.nih.gov/34487574/Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosisWu RW & Lin TK
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12278Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesionYamamoto M
https://pubmed.ncbi.nlm.nih.gov/36072649/Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 VaccinationAryanian et al (2)
https://pubmed.ncbi.nlm.nih.gov/36068793/Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapyEl-Behaedi et al
https://pubmed.ncbi.nlm.nih.gov/36062201/A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch testsSeol EJ et al
https://pubmed.ncbi.nlm.nih.gov/35604041/Nail psoriasis: a rare mRNA COVID-19 vaccine reactionLamberti A et al
https://pubmed.ncbi.nlm.nih.gov/36098769/New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature reviewSagy et al
https://pubmed.ncbi.nlm.nih.gov/36035769/Sever erythema multiforme post-COVID-19 moderna vaccine: Case report and literature reviewFadul et al
https://pubmed.ncbi.nlm.nih.gov/36035747/COVID-19 Vaccination Related Exacerbations of Hair Loss in Patients with Moderate to Severe Alopecia Areata on Systemic TherapyBabadjouni et al
https://pubmed.ncbi.nlm.nih.gov/36004038/Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent GirlRubaian et al
https://pubmed.ncbi.nlm.nih.gov/35991953/Sweet syndrome following Moderna COVID-19 vaccine: A case reportPelchat et al
https://pubmed.ncbi.nlm.nih.gov/35975094/Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative ReviewAbdalla & Ebrahim
https://pubmed.ncbi.nlm.nih.gov/35966159/Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike proteinTriwatcharikorn et al
https://pubmed.ncbi.nlm.nih.gov/35936173/COVID-19 Vaccine Booster-Induced DermatographismAmjad et al
https://pubmed.ncbi.nlm.nih.gov/35922892/Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccineNahm et al
https://pubmed.ncbi.nlm.nih.gov/35916826/Eyelid edema following the first Pfizer-BioNTech COVID-19 vaccination: is it a coincidence?Baysal & Gobeka
https://pubmed.ncbi.nlm.nih.gov/35911257/Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 VaccinationShansal
https://pubmed.ncbi.nlm.nih.gov/35892478/Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccinede Lorenzi et al
https://pubmed.ncbi.nlm.nih.gov/35880298/Under-awareness and over-diagnosis of COVID-19 vaccine ‘allergy’Chiang V et al
https://pubmed.ncbi.nlm.nih.gov/35875513/Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccinationMuqrin et al
https://pubmed.ncbi.nlm.nih.gov/35855232/Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case SeriesShah & Busquets
https://pubmed.ncbi.nlm.nih.gov/35851250/Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 casesRaccampo et al
https://pubmed.ncbi.nlm.nih.gov/35850789/Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccineAhmer et al
https://pubmed.ncbi.nlm.nih.gov/35850104/ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 VaccineHasbani & Uthman
https://pubmed.ncbi.nlm.nih.gov/35845348/New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 casesGui H et al
https://pubmed.ncbi.nlm.nih.gov/35835178/Gianotti-Crosti Syndrome of Atypical Location in an Adult Following SARS-CoV-2 VaccinationPestana et al
https://pubmed.ncbi.nlm.nih.gov/35832214/ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccineYadav et al
https://pubmed.ncbi.nlm.nih.gov/35812079/Acute vulvar ulcers and the COVID-19 booster vaccineSalusti-Simpson et al
https://pubmed.ncbi.nlm.nih.gov/35811413/Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic reviewAntoñanzas et al
https://pubmed.ncbi.nlm.nih.gov/35789676/Blaschkolinear acquired inflammatory skin eruption (blaschkitis) following COVID-19 vaccinationRovira-López & Pujol
https://pubmed.ncbi.nlm.nih.gov/35756074/Vitiligo of the arm after COVID-19 vaccinationSingh R et al
https://pubmed.ncbi.nlm.nih.gov/36185929/Relapse of Palmoplantar Pustulosis Following COVID-19 VaccinationKatsuie et al
https://pubmed.ncbi.nlm.nih.gov/36183151/Lichen planus pigmentosus post COVID-19-vaccinationChaima et al
https://pubmed.ncbi.nlm.nih.gov/36182117/Livedo reticularis after COVID-19 vaccinationHorino et al
https://pubmed.ncbi.nlm.nih.gov/36164291/New-Onset Lichen Planus Induced by the Pfizer COVID-19 VaccineAlghamdi et al
https://pubmed.ncbi.nlm.nih.gov/36136900/Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccineGirolami et al
https://pubmed.ncbi.nlm.nih.gov/36219526/Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literatureBechtold & Owczarczyk-Saczonek
https://pubmed.ncbi.nlm.nih.gov/36125778/Asymmetric Periflexural Exanthem in an Adult Patient After Pfizer-BioNTech COVID-19 VaccineThabouti et al
https://pubmed.ncbi.nlm.nih.gov/36259862/’A new eruption of bullous pemphigoid following mRNA COVID-19 vaccinationDaines et al
https://pubmed.ncbi.nlm.nih.gov/36340858/Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccineBakr et al
https://pubmed.ncbi.nlm.nih.gov/36340561/A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 VaccineNida SS et al
https://pubmed.ncbi.nlm.nih.gov/36314709/A Histologic Timeline of a Delayed Hypersensitivity Reaction after the COVID-19 Pfizer BoosterStrong HA et al
https://pubmed.ncbi.nlm.nih.gov/36304618/Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)Batta et al
https://pubmed.ncbi.nlm.nih.gov/36302245/Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccineSapsford & Wood
https://pubmed.ncbi.nlm.nih.gov/36298511/Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated VitiligoMacca et al
https://pubmed.ncbi.nlm.nih.gov/35595719/New onset and exacerbation of oral lichenoid mucositis following SARS-CoV-2 infection or vaccinationAlabdulaaly et al
https://pubmed.ncbi.nlm.nih.gov/35560571/Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genesTachibana et al
https://pubmed.ncbi.nlm.nih.gov/34897817/Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patientKnechtl et al
https://pubmed.ncbi.nlm.nih.gov/36592149/Tozinameran (Pfizer-BioNTech COVID-19 vaccine)-induced AGEP-DRESS syndromeTay WC et al
https://pubmed.ncbi.nlm.nih.gov/36592047/mRNA-1273 COVID-19 vaccine-induced Steven-Johnson syndromeLo HK et al
https://pubmed.ncbi.nlm.nih.gov/36591352/Rash, Abdominal Pain, Proteinuria, and AKI after COVID-19 VaccinationLazoff et al
https://pubmed.ncbi.nlm.nih.gov/36590078/An asymmetric morbilliform eruption in an adult maleYelich et al
https://pubmed.ncbi.nlm.nih.gov/36562098/A rare presentation of rapidly progressing myopathy in an adolescentPepys et al
https://pubmed.ncbi.nlm.nih.gov/36540524/A Case Report of Exfoliative Bullous Rash Following AstraZeneca VaccineSaleem & Goh
https://pubmed.ncbi.nlm.nih.gov/36531266/Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccineFrederiks et al
https://pubmed.ncbi.nlm.nih.gov/36514459/Generalized fixed drug eruption following Pfizer-BioNtech COVID-19 vaccinationKabir S et al
https://pubmed.ncbi.nlm.nih.gov/36504544/Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case ReportAhmed F et al
https://pubmed.ncbi.nlm.nih.gov/36503530/Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccineDi Bona et al
https://pubmed.ncbi.nlm.nih.gov/36466142/Localized eczematous rash affecting left and right regions of breast and shoulder after Ad26.COV2.S vaccine against COVID-19 in a 30-year-old woman with comorbiditiesAnasiewicz et al
https://pubmed.ncbi.nlm.nih.gov/36451671/Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two casesKim JH et al
https://pubmed.ncbi.nlm.nih.gov/36451284/Erythema nodosum after COVID-19 vaccine: Report of two pediatric casesGonzalez-Canete et al
https://pubmed.ncbi.nlm.nih.gov/36448713/Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID-19 vaccinationWang HJ et al
https://pubmed.ncbi.nlm.nih.gov/36426538/Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case ReportKim YC et al
https://pubmed.ncbi.nlm.nih.gov/36423067/A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association?Ambrogio et al
https://pubmed.ncbi.nlm.nih.gov/36406337/Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIVBressler et al
https://pubmed.ncbi.nlm.nih.gov/36647894/An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?Peterle et al
https://pubmed.ncbi.nlm.nih.gov/36638370/Psoriasiform Dermatitis Associated With the Moderna COVID-19 Messenger RNA VaccineDaneshbod et al
https://pubmed.ncbi.nlm.nih.gov/36626570/Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature ReviewLiu Ya et al
https://pubmed.ncbi.nlm.nih.gov/36624889/A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 VaccinationGomez YS et al
https://pubmed.ncbi.nlm.nih.gov/36683345/Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on «cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine» by Luo et alMartora et al
https://pubmed.ncbi.nlm.nih.gov/35170477/Acantholytic Dyskeratosis Post-COVID VaccinationYang K et al
https://pubmed.ncbi.nlm.nih.gov/36514624/COVID-19 Vaccine: A Common Suspect but Rare Culprit in Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) SyndromeHanna & Yang
https://pubmed.ncbi.nlm.nih.gov/36057958/Erythema multiforme following vaccination for SARS-CoV-2: Report of a case and review of the literature – Secondary PublicationKobyashi Y et al
https://pubmed.ncbi.nlm.nih.gov/34821413/Case of atypical erythema multiforme following coronavirus disease 2019 vaccinationIwasawa et al (2)
https://pubmed.ncbi.nlm.nih.gov/34865149/Erythema multiforme after SARS-CoV-2 messenger RNA vaccination*NO AUTHOR*
https://pubmed.ncbi.nlm.nih.gov/34547145/Nevocentric erythema multiforme after SARS-COV-2 vaccineScharf C et al
https://pubmed.ncbi.nlm.nih.gov/34667612/Erythema Multiforme Major following SARS-CoV-2 vaccineSaibene et al
https://pubmed.ncbi.nlm.nih.gov/35492355/Case Report: Idiopathic Subcutaneous Thrombotic VasculopathyGodbe et al
https://pubmed.ncbi.nlm.nih.gov/35441091/Eyelid erythema after coronavirus vaccinationBárcena-Dahl et al
https://pubmed.ncbi.nlm.nih.gov/35652448/Urticarial vasculitis after COVID-19 vaccination: A case report and literature reviewOno et al
https://pubmed.ncbi.nlm.nih.gov/36511288/Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19Souza EN et al
https://pubmed.ncbi.nlm.nih.gov/36246778/New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literatureKhanna et al
https://pubmed.ncbi.nlm.nih.gov/34529877/Cutaneous small-vessel vasculitis following COVID-19 vaccineKar BR et al
https://pubmed.ncbi.nlm.nih.gov/35690533/A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 VaccinationBall-Burack & Kosowsky
https://pubmed.ncbi.nlm.nih.gov/36146490/Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature ReviewWang RL et al
https://pubmed.ncbi.nlm.nih.gov/35818815/Symptomatic hyponatremia after ChAdOx1 nCoV-19 coronavirus disease-19 vaccinationChienwichai et al